• Enhanced Glycopeptide A40926 Production via Engineered Nonom

  2026-06-03

  This study demonstrates a 30.6% improvement in glycopeptide antibiotic A40926 production through polygenic engineering and media optimization in Nonomuraea gerenzanensis. The findings provide an advanced model for boosting industrial antibiotic yields by combining targeted genetic and fermentation strategies.

• NF 340: Unmasking the P2Y11 Pathway in Cancer Invasion Resea

  2026-06-03

  Explore how NF 340, a potent P2Y11 antagonist, uniquely enables researchers to dissect purinergic signaling in cancer invasion and immunology studies. This article delivers a deep dive into mechanism, experimental design, and the latest translational insights.

• BV6 IAP Antagonist: Protocols and Innovations in Apoptosis R

  2026-06-02

  BV6, a selective IAP antagonist, unlocks powerful workflows for apoptosis induction in cancer and endometriosis models, enabling enhanced radiosensitization and chemosensitization. This article delivers advanced, evidence-based protocol guidance, troubleshooting tips, and a translation of the latest mitochondrial apoptosis findings into practical bench strategies.

• Transdermal HA-Lipid Nanoparticle Delivery of PTEN mRNA in M

  2026-06-02

  This study introduces hyaluronate-conjugated lipid nanoparticles (HA-LNPs) for the targeted transdermal delivery of PTEN mRNA, restoring tumor suppressor function in melanoma. The innovation lies in enhanced skin penetration, CD44-mediated tumor targeting, and improved immune activation, suggesting a clinically translatable approach for localized, non-viral mRNA-based cancer immunotherapy.

• EZ Cap™ Human PTEN mRNA: Optimizing Tumor Suppressor Gene De

  2026-06-01

  EZ Cap™ Human PTEN mRNA enables robust restoration of PTEN function, empowering researchers to overcome resistance in cancer immunotherapy with high-fidelity, Cap 1-modified mRNA. This guide breaks down advanced workflows, protocol enhancements, and troubleshooting strategies to maximize translational efficiency and stability in both conventional and novel delivery systems.

• CDK9 Inhibitor (A3294): Technical Workflow and Protocol Guid

  2026-06-01

  CDK9 inhibitor (A3294) enables selective inhibition of cyclin dependent kinase 9, supporting precise studies of transcription elongation and HIV-1 propagation without broad cytotoxicity. It is not intended for protocols requiring non-selective CDK inhibition or long-term storage of working solutions.

• Advancing In Vitro Assessment of Cancer Drug Responses

  2026-05-31

  Schwartz's dissertation introduces a refined in vitro framework distinguishing between proliferative arrest and cell death in cancer drug evaluation. This approach clarifies mechanistic drug effects and supports more precise experimental interpretation, with significant methodological implications for cancer research.

• Pepstatin A: Benchmark Aspartic Protease Inhibitor for Advan

  2026-05-30

  Pepstatin A delivers precise, reproducible inhibition of aspartic proteases in workflows spanning viral protein processing to osteoclast differentiation. APExBIO’s ultra-pure formulation ensures robust assay performance and troubleshooting flexibility for translational research.

• Fluorescein Tyramide: Expanding the Horizon of Ultra-Sensiti

  2026-05-29

  Discover how Fluorescein Tyramide advances fluorescent labeling dye technology for precise neural circuit mapping and low-abundance target detection. This article offers a deeper analysis of assay optimization and translational neuroscience applications, going beyond standard protocol discussions.

• GKT137831: Redox Control, Ferroptosis, and Translational Imp

  2026-05-29

  Explore how GKT137831, a dual NADPH oxidase Nox1/Nox4 inhibitor, enables advanced redox and ferroptosis research. This article dives deeper into molecular mechanisms, the link to plasma membrane lipid remodeling, and translational assay design.

• AICAR and AMPK: Advancing Inflammation Research in Metabolic

  2026-05-28

  This thought-leadership article explores how AICAR-mediated AMPK activation provides translational researchers with mechanistic and strategic tools to dissect and modulate inflammation in metabolic disease contexts. Integrating new evidence from macrophage polarization studies, comparative product insights, and actionable protocol guidance, we chart a path from experimental innovation to clinical vision.

• Ruxolitinib (INCB018424): Decoding JAK-STAT Modulation in Im

  2026-05-28

  Explore the molecular precision of Ruxolitinib (INCB018424) in JAK-STAT pathway inhibition and its transformative role in myeloproliferative disorder research. This article uniquely bridges foundational kinase biology with advanced assay design, offering a critical analysis beyond protocol optimization.

• 0.4% Trypan Blue Solution: Technical Guide for Cell Viabilit

  2026-05-27

  0.4% Trypan Blue Solution enables direct discrimination of live and dead cells during viability measurement, cell counting, and cytotoxicity assessments. This reagent is intended for laboratory research workflows and should not be used for diagnostic or clinical applications.

• Spiroplasma eriocheiris Entry Pathways in Drosophila S2 Cell

  2026-05-27

  Wei et al. elucidate the cellular entry mechanisms of Spiroplasma eriocheiris in Drosophila Schneider 2 (S2) cells, demonstrating reliance on clathrin-mediated endocytosis and macropinocytosis. The study reveals that microtubule and actin cytoskeleton integrity is critical for infection, providing a refined model for host-pathogen interaction in invertebrate cell systems.

• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor-S

  2026-05-26

  This study introduces a patient-derived gastric cancer assembloid model that integrates matched tumor organoids with autologous stromal cell subpopulations, capturing tumor microenvironment complexity. The approach enhances preclinical drug testing, revealing stromal influence on drug response and resistance mechanisms, with significant implications for personalized therapy development.

16242 records 1/1083 page Next 12345 下5页 Last page